Interventional treatment for ischemic-type biliary lesion after liver transplantation
-
摘要:
目的 探讨肝移植术后缺血性胆道病变(ITBL)患者接受介入治疗的安全性及疗效。 方法 回顾性分析2006年1月至2014年2月在中山大学附属第三医院介入血管科接受介入治疗的76例肝移植术后ITBL患者的影像及临床资料。按胆道造影表现分为3组:肝门区狭窄组(28例), 肝内多发狭窄组(42例), 胆汁瘤组(6例)。治疗方式包括单纯经皮经肝胆管引流术(PTBD)、PTBD配合球囊扩张、PTBD配合球囊扩张及胆道内支架术。引流方式包括胆道外引流及胆道内外引流。术后随访并观察疗效及胆道并发症。 结果 76例患者的PTBD首次成功率为97%(74/76)。介入治疗的总体治愈率、好转率及无效率分别为21%(16/76)、51%(39/76)、28% (21/76)。其中, 肝门区狭窄组治愈10例(36%), 好转16例(57%), 无效2例(7%), 治疗有效22例(93%); 多发性狭窄组治愈6例(14%), 好转21例(50%), 无效15例(36%), 治疗有效27例(64%); 胆汁瘤组好转2例(2/6), 无效4例(4/6)。肝门区狭窄患者的疗效优于多发性狭窄患者(P < 0.05), 多发性狭窄患者的疗效优于胆汁瘤患者(P < 0.001)。引流管期间主要并发症为胆道感染, 其中外引流及内外引流胆道感染发生率分别为20%(13/64)及67%(8/12), 比较差异有统计学意义(P < 0.001)。 结论 PTBD是治疗肝移植术后ITBL的安全、有效手段之一。结合球囊扩张及内支架置入可有效改善患者症状, 提高生存质量。采用胆道外引流可显著降低胆道感染发生率。 Abstract:Objective To investigate the safety and efficacy of interventional treatment for ischemic-type biliary lesion(ITBL) after liver transplantation(LT). Methods The clinical and imaging data of 76 patients with ITBL after LT, who received interventional treatment in the Department of Interventional Vascular Radiology of the Third Affiliated Hospital of Sun Yat-sen University from January 2006 to February 2014, were retrospectively analyzed. On the basis of the cholangiographic appearance, patients were classified into 3 groups:hilar biliary stricture group(n=28), multifocal biliary stricture group(n=42), and biloma group (n=6). The modalities of interventional treatment were percutanous transhepatic biliary drainage(PTBD), PTBD combined with balloon dilation, PTBD combined with balloon dilation and plastic stent implantation. The methods of biliary drainage included external drainage and external-internal drainage. All the patients were followed up after treatment. The curative effect and biliary complication was observed. Results The first successful rate of PTBD was 97%(74/76). The total curative rate, improvement rate and ineffective rate of interventional treatment were 21%(16/76), 51%(39/76) and 28%(21/76). In hilar biliary stricture group, the cure, improvement and inefficacy rates were 36%(10/28), 57%(16/28)and 7%(2/28). The efficacy rate was 93%(22/28). In multifocal biliary stricture group, the cure, improvement and inefficacy rates were 14%(6/42), 50%(21/42)and 36%(15/42). The efficacy rate was 64%(27/42). In biloma group, 2 cases(2/6) were cured and treatment of 4 cases was ineffective. The efficacy of hilar biliary stricture group was better than that of multifocal biliary stricture group(P < 0.05). The efficacy of multifocal biliary stricture group was better than that of biloma group(P < 0.001). The main biliary complication was biliary tract infection during drainage. The rates of bile tract infections were 20%(13/64)and 67%(8/12) in patients with external drainage and external-internal drainage, respectively. There was significant difference between these two items (P < 0.001). Conclusions PTBD is a safe and effective therapeutic modality for ITBL after LT, which combined with balloon dilation and biliary stent implantation can improve patients' clinical symptoms, elevate patients' quality of life. The biliary external drainage can decrease the rate of biliary tract infection significantly. -
图 1 部分肝移植术后缺血性胆道病变患者的介入治疗经过
注:A~D图为1例64岁女性患者(原发性肝癌肝移植术后2个月);A图胆管造影示肝内胆管重度扩张,肝门区胆管及胆管吻合口均可见狭窄(肝门区狭窄组);B图球囊扩张胆管狭窄段后,给予胆道引流治疗;C图:引流管直径逐渐增大至12 F;D图复查示胆管狭窄明显改善,治疗12个月后,给予拔管,达到治愈。E~H图为1例48岁男性患者(乙型病毒性肝炎后肝硬化肝移植术后1年);E图胆管造影示示供肝胆管内多发性狭窄,伴弥漫性胆泥形成(多发性狭窄组);F图给予PTBD治疗,引流管成袢于右侧肝内胆管内;G图引流6个月后患者血清总胆红素基本正常,复查胆管形态改善不明显,植入胆道内涵管2枚(患者无法耐受长期带管);H图置入引流管继续引流1周后给予拔管,随访38个月症状无复发。I~K图为1例31岁男性患者(重型乙型病毒性肝炎肝移植术后1年);I图胆管造影示肝内多发胆汁瘤形成,与肝内胆管沟通,胆管吻合口狭窄(胆汁瘤组);J图给予PTBD治疗,引流3个月后复查胆汁瘤增多,吻合口狭窄改善,患者黄疸症状减轻;K图引流5个月后复查示胆管系统进一步恶化,遂行再次肝移植
Figure 1. The procedures of interventional treatments for partial patients with ITBL after liver transplantation
-
[1] Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation[J]. Transpl Int, 2010, 23(1):14-22. doi: 10.1111/tri.2009.23.issue-1 [2] Mourad MM, Algarni A, Liossis C, et al. Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation[J]. World J Gastroenterol, 2014, 20(20):6159-6169. doi: 10.3748/wjg.v20.i20.6159 [3] Lu NN, Huang Q, Wang JF, et al. Non-anastomotic biliary strictures following orthotopic liver transplantation:treatment with percutaneous transhepatic biliary drainage[J]. Hepatogastroenterology, 2012, 59(120):2569-2572. http://www.medscape.com/medline/abstract/22591678 [4] Gwon DI, Sung KB, Ko GY, et al. Dual catheter placement technique for treatment of biliary anastomotic strictures after liver transplantation[J]. Liver Transpl, 2011, 17(2):159-166. doi: 10.1002/lt.v17.2 [5] Wang CM, Li X, Song S, et al. Newly designed Y-configured single-catheter stenting for the treatment of hilar-type nonanastomotic biliary strictures after orthotopic liver transplantation[J]. Cardiovasc Intervent Radiol, 2012, 35(1):184-189. doi: 10.1007/s00270-011-0214-y [6] Piardi T, Greget M, Audet M, et al. Biliary strictures after liver transplantation:is percutaneous treatment indicated?[J]. Ann Transplant, 2011, 16(2):5-13. doi: 10.12659/AOT.881858 [7] Sung RS, Campbell DA Jr, Rudich SM, et al. Long-term follow-up of percutanious transhepatic balloon cholangioplasty in the management of biliary strictures after liver transplantation[J]. Transplantation, 2004, 77(1):110-115. doi: 10.1097/01.TP.0000101518.19849.C8 [8] Fisher A, Miller CH. Ischemic-type biliary strictures in liver allografts:the Achilles heel revisited?[J]. Hepatology, 1995, 21(2):589-591. doi: 10.1002/(ISSN)1527-3350 [9] Nakamura N, Nishida S, Neff GR, et al. Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation:an analysis of 1, 113 liver transplantations at a single center[J].Transplantation, 2005, 79(4):427-432. doi: 10.1097/01.TP.0000152800.19986.9E [10] Sunku B, Salvalaggio PRO, Donaldson J, et al. Outcomes and risk factors for failure of radiologic treatment of biliary strictures in pediatric liver transplant recipients[J]. Liver Transpl, 2006, 12(5):821-826. doi: 10.1002/(ISSN)1527-6473 [11] Safdar N, Said A, Lucey MR, et al. Infected bilomas in liver transplant recipients:clinical features, optimal management, and risk factors for mortality[J]. Clin Infect Dis, 2004, 39(4):517-525. doi: 10.1086/422644 [12] Said A, Safdar N, Lucey MR, et al. Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention[J]. Am J Transplant, 2004, 4(4):574-582. doi: 10.1111/ajt.2004.4.issue-4 [13] Kao D, Zepeda-Gomez S, Tandon P, et al. Managing the post-liver transplantation anastomotic biliary stricture:multiple plastic versus metal stents:a systematic review[J].Gastrointest Endosc, 2013, 77(5):679-691. doi: 10.1016/j.gie.2013.01.015 [14] Hsieh TH, Mekeel KL, Crowell MD, et al. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation:outcomes after maximal stent therapy[J]. Gastrointest Endosc, 2013, 77(1):47-54. doi: 10.1016/j.gie.2012.08.034 [15] Perkins JD. Balloon dilation only versus balloon dilation plus stenting for posttransplantation biliary strictures[J]. Liver Transpl, 2009, 15(1):106-110. doi: 10.1002/lt.v15:1 [16] Nacif LS, Bernardo WM, Bernardo L, et al. Endoscopic treatment of post-liver transplantation anastomotic biliary stricture:systematic review andmeta-analysis[J]. Arq Gastroenterol, 2014, 51(3):240-249. doi: 10.1590/S0004-28032014000300014 [17] Siriwardana HP, Siriwardena AK. Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture[J]. Ann Surg, 2005, 242(1):10-19. doi: 10.1097/01.sla.0000167761.70021.4d [18] Tabibian JH, Asham EH, Goldstein L, et al. Endoscopic treatment with multiple stents for post-liver transplantation nonanastomotic biliary strictures[J]. Gastrointest Endosc, 2009, 69(7):1236-1243. doi: 10.1016/j.gie.2008.09.057 [19] 易述红, 易慧敏, 傅斌生, 等.联合肝门板的肝门-空肠吻合术治疗肝移植术后缺血型胆道病变患者[J/CD].中华肝脏外科手术学电子杂志, 2013, 2(1):14-18.Yi SH, Yi HM, Fu BS, et al. Roux-en-Y hepatojejunostomy combined with hilar plate in the treatment of ischemic-type biliary lesion after liver transplantation[J/CD]. Chin J Hepatic Surg:Electr Edit, 2013, 2(1):14-18.